GrowthWorks

GrowthWorks, established in 1992, is a Canadian venture capital management company headquartered in Vancouver. It specializes in managing regional venture capital funds across the country, with a focus on early-stage investments in growth-oriented companies within the technology, cleantech, and healthcare sectors. The firm structures strategic investments, values portfolio assets conservatively, builds industry connections, and diversifies to minimize risk. GrowthWorks offers regional expertise with national reach, providing strategic management support and advice to portfolio companies to drive growth and success.

141 past transactions

Spotta

Series A in 2023
Spotta Ltd is a company that specializes in developing smart pest control systems aimed at the hotel and lodging industry, focusing on the early detection of bed bugs. Founded in 2018 and headquartered in Cambridge, United Kingdom, Spotta offers a battery-powered insect monitoring sensor that alerts users to potential bed bug infestations. This innovative technology analyzes detection data to ensure that notifications pertain only to genuine incidents, allowing hotels to proactively prevent bed bugs from spreading and facilitating more efficient and cost-effective treatment options. By leveraging these systems, lodging providers can enhance guest satisfaction and maintain a pest-free environment.

ClearRisk

Venture Round in 2021
ClearRisk, Inc. specializes in providing cloud-based software solutions tailored for the insurance industry in North America. Founded in 2006 and based in St. John's, Canada, the company offers three main products: ClearRisk Manager, an online platform that helps organizations develop and implement risk management plans; ClearRisk Tracker, designed for mid-market municipalities to manage insurance claims, exposures, incidents, and policies; and ClearRisk Underwriter, a web application that facilitates automation and collaboration for insurance brokers and underwriters. ClearRisk's solutions enable insurance professionals, including brokers and risk managers, to efficiently organize, analyze, and automate their risk and claims data, ultimately enhancing their risk management capabilities. The company was previously known as Livyer Enterprises Ltd. before rebranding in August 2008.

HIGHLINEvc

Pre Seed Round in 2016
HIGHLINE is a pre-seed investor and acceleration platform that supports digital startups in securing follow-on capital, leveraging a network of prominent venture capitalists from its offices in Vancouver and Toronto. Unlike traditional accelerators, HIGHLINE operates without rigid start or end dates, allowing founders to seek advice and support at any time. The platform offers access to a premium network and hosts monthly events for founders, fostering an environment for collaboration and growth. Additionally, HIGHLINE addresses fundraising challenges and collaborates with incubators to provide specialized programming tailored to the needs of emerging companies. The organization was formed in August 2014 through the merger of Growlab Ventures and Extreme Startups.

Introhive

Series B in 2015
Introhive, Inc. is a Canadian company based in Fredericton that specializes in developing contact mining software applications and a revenue acceleration platform. Founded in 2012 by Jody Glidden and Stewart Walchli, Introhive offers a Software as a Service (SaaS) solution aimed at enhancing customer experience management and increasing organizational revenues. The platform integrates relationship intelligence into customer relationship management (CRM) systems through data automation and sales acceleration features. It enables organizations to transform disorganized data into actionable insights, facilitating processes such as sales hiring, prospecting, territory assignment, renewals, and lead scoring. Through its enterprise relationship management solution, Introhive provides valuable insights that drive productivity and improve CRM adoption.

Switch Materials

Series C in 2015
Switch Materials Inc. specializes in innovative smart window solutions for the automotive industry, catering to original equipment manufacturers (OEMs) and Tier 1 suppliers. Founded in 2007 and located in Burnaby, Canada, the company focuses on developing advanced materials based on proprietary organic molecules that can change their optical properties upon command. This technology enables various applications, including photochromic and electrochromic systems that automatically adjust the tint of sunroofs to minimize heat and glare. Additionally, Switch Materials' expertise extends to molecular electronics and health sciences, with potential uses in optical filters, photochromic inks, and molecular sensors. The company's research and development is conducted in state-of-the-art laboratories and facilities at 4D LABS, a prominent materials science research center affiliated with Simon Fraser University.

General Fusion

Venture Round in 2015
General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.

BuildDirect

Series C in 2014
BuildDirect Technologies Inc. operates an online marketplace that connects homeowners and home improvement professionals in North America with global suppliers of building materials. Founded in 1999 and based in Vancouver, Canada, the company offers a wide range of products, including flooring, decking, tiles, and other building materials. Its platform facilitates the buying and selling of these materials, enhancing accessibility for consumers and professionals alike. BuildDirect's services also include BuildDirect Gateway, a global supply chain platform that provides third parties with access to advanced warehousing and logistics solutions, streamlining the shipping process from manufacturing to last-mile delivery. The company generates the majority of its revenue from its primary platform in the United States.

Verold (zyenti)

Series A in 2014
Verold is an online visual editor that allows users to integrate 3D models into their presentations. The platform provides a studio that enables users to customize the lighting and environment setup of their project. They can also add animations, audio, and video assets and share their output in the web through Verold’s embeddable player. In 2015, Verold was acquired by Box.

Cooledge Lighting

Venture Round in 2014
Cooledge Lighting, Inc. specializes in innovative LED lighting solutions, particularly utilizing light sheet technology to create adaptable, flat, and flexible lighting products. The company offers a range of lighting solutions, including square products for wide area illumination and backlighting, as well as line lighting designed for continuous and uniform architectural accents. These products enable lighting designers and architects to seamlessly integrate lighting into various projects, from large area backlighting to intricate millwork and ceiling systems. Founded in 2009 and headquartered in Richmond, Canada, Cooledge Lighting also maintains additional operations in the United States and Germany, positioning itself as a key player in the solid-state lighting market.

Smart Skin Technologies

Series A in 2014
Smart Skin Technologies Inc. is a technology development company based in Fredericton, Canada, with an additional office in Munich, Germany. Founded in 2009, the company specializes in the development and commercialization of a pressure-sensitive skin technology that has diverse applications. Its flagship product, Quantifeel, is a packaging pressure monitoring system designed to measure line pressure and 3D orientation in various types of packaging, including glass, cans, and PET. In addition to its existing products, Smart Skin Technologies is actively developing patent-pending pressure sensing technology for industrial applications and sports, aiming to expand its footprint across multiple verticals.

ResponseTek

Venture Round in 2014
ResponseTek Networks Corp. is a leading provider of Customer Experience Management (CEM) software, focused on enhancing customer satisfaction by transforming customer feedback into actionable insights. The ResponseTek Listening Platform connects major corporations, including HSBC and Vodafone, with their customers across various touchpoints such as retail, call centers, and online services. By employing diverse methods, including SMS surveys and social media monitoring, ResponseTek enables organizations to obtain a comprehensive view of the customer experience, supported by both quantitative data and qualitative feedback. Headquartered in Vancouver, the company also has offices in Toronto and London, UK, and aims to integrate customer experience data across organizations to eliminate information silos and foster improvements in customer satisfaction.

BTI Systems

Series D in 2014
BTI Systems Inc. is a company that specializes in developing and marketing cloud and metro networking software and systems for carriers, colocation, content, and service providers, as well as cloud infrastructure companies globally. Its product offerings include the BTI Intelligent Cloud Connect platforms for cloud service delivery, high-bandwidth Packet Optical Transport network infrastructure for various metro and regional services, and Access and Aggregation Platforms for carrier Ethernet business services and mobile backhaul applications. Additionally, BTI provides Ethernet Access Platforms to extend services to customer premises and control software for centralized network management. Founded in 2000 and based in Kanata, Canada, BTI also offers professional services such as network planning, systems engineering, and installation. The company serves over 380 customers worldwide and operates regional sales, marketing, and research and development centers internationally. BTI Systems is a subsidiary of Juniper Networks, as of January 2016.

INETCO Systems Limited

Venture Round in 2013
INETCO Systems Limited is a Canadian company specializing in real-time transaction monitoring and analytics solutions for various sectors, including banking, retail, healthcare, and telecommunications. Founded in 1984 and headquartered in Burnaby, the company offers a range of products designed to enhance customer experience and operational efficiency in digital and self-service payment environments. Its flagship product, INETCO Insight, is utilized by banks and retailers in over 35 countries to monitor transactions, detect payment fraud, and address performance issues. INETCO also provides additional software for customer analytics, omni-channel banking, mobile and online banking solutions, and professional services, which include implementation and training. The company aims to support organizations in their digital transformation efforts while ensuring the reliability and safety of payment transactions.

Introhive

Series B in 2013
Introhive, Inc. is a Canadian company based in Fredericton that specializes in developing contact mining software applications and a revenue acceleration platform. Founded in 2012 by Jody Glidden and Stewart Walchli, Introhive offers a Software as a Service (SaaS) solution aimed at enhancing customer experience management and increasing organizational revenues. The platform integrates relationship intelligence into customer relationship management (CRM) systems through data automation and sales acceleration features. It enables organizations to transform disorganized data into actionable insights, facilitating processes such as sales hiring, prospecting, territory assignment, renewals, and lead scoring. Through its enterprise relationship management solution, Introhive provides valuable insights that drive productivity and improve CRM adoption.

ClearRisk

Venture Round in 2013
ClearRisk, Inc. specializes in providing cloud-based software solutions tailored for the insurance industry in North America. Founded in 2006 and based in St. John's, Canada, the company offers three main products: ClearRisk Manager, an online platform that helps organizations develop and implement risk management plans; ClearRisk Tracker, designed for mid-market municipalities to manage insurance claims, exposures, incidents, and policies; and ClearRisk Underwriter, a web application that facilitates automation and collaboration for insurance brokers and underwriters. ClearRisk's solutions enable insurance professionals, including brokers and risk managers, to efficiently organize, analyze, and automate their risk and claims data, ultimately enhancing their risk management capabilities. The company was previously known as Livyer Enterprises Ltd. before rebranding in August 2008.

Oris4

Venture Round in 2013
Oris4 is a cloud-based enterprise content management platform that focuses on enhancing the organization and retrieval of content across various channels. It integrates multiple cloud storage solutions, such as Box, Dropbox, and Google Drive, alongside email applications like Gmail and Office 365, allowing users to consolidate their information sources. Additionally, Oris4 is fully integrated with Salesforce, enabling users to access all account-related content directly on their Salesforce pages. This comprehensive approach streamlines content management, making it easier for organizations to store, share, and search for vital information efficiently.

BTI Systems

Venture Round in 2013
BTI Systems Inc. is a company that specializes in developing and marketing cloud and metro networking software and systems for carriers, colocation, content, and service providers, as well as cloud infrastructure companies globally. Its product offerings include the BTI Intelligent Cloud Connect platforms for cloud service delivery, high-bandwidth Packet Optical Transport network infrastructure for various metro and regional services, and Access and Aggregation Platforms for carrier Ethernet business services and mobile backhaul applications. Additionally, BTI provides Ethernet Access Platforms to extend services to customer premises and control software for centralized network management. Founded in 2000 and based in Kanata, Canada, BTI also offers professional services such as network planning, systems engineering, and installation. The company serves over 380 customers worldwide and operates regional sales, marketing, and research and development centers internationally. BTI Systems is a subsidiary of Juniper Networks, as of January 2016.

Introhive

Series A in 2012
Introhive, Inc. is a Canadian company based in Fredericton that specializes in developing contact mining software applications and a revenue acceleration platform. Founded in 2012 by Jody Glidden and Stewart Walchli, Introhive offers a Software as a Service (SaaS) solution aimed at enhancing customer experience management and increasing organizational revenues. The platform integrates relationship intelligence into customer relationship management (CRM) systems through data automation and sales acceleration features. It enables organizations to transform disorganized data into actionable insights, facilitating processes such as sales hiring, prospecting, territory assignment, renewals, and lead scoring. Through its enterprise relationship management solution, Introhive provides valuable insights that drive productivity and improve CRM adoption.

Ambit Biosciences

Venture Round in 2012
Ambit Biosciences is a privately-held biopharmaceutical company that specializes in the discovery and development of small molecule kinase inhibitors aimed at treating cancer and inflammatory diseases. The company's lead compound, AC220, is a selective and orally bioavailable inhibitor of FMS-like tyrosine kinase-3 (FLT3), currently undergoing clinical trials for patients with relapsed or refractory acute myeloid leukemia (AML). Ambit is collaborating with Astellas Pharma Inc. to jointly develop and commercialize FLT3 kinase inhibitors across various therapeutic areas. In addition to AC220, Ambit's clinical pipeline features AC480, a pan-HER inhibitor, and AC430, an oral inhibitor of JAK2. Furthermore, the company has several preclinical candidates, including CEP-32496, a BRAF inhibitor that is licensed to Cephalon. Through its innovative approach, Ambit aims to enhance treatment outcomes for cancer patients.

D-Wave Systems

Venture Round in 2012
D-Wave Systems Inc. specializes in the development and integration of superconducting quantum computers. As the first commercial supplier of quantum computers, the company offers products such as The D-Wave Two System, D-Wave Hybrid—a hybrid workflow platform for quantum-classical applications—and Leap, a cloud-based service that enables real-time access to quantum computing resources along with open-source development tools and educational materials. D-Wave's quantum computers are applied across various sectors, including defense, finance, energy, and academia, addressing challenges in mission planning, logistics, machine learning, optimization problems, and more. In addition to its quantum computing systems, the company provides professional services, training, and customer support to enhance user experience. Founded in 1999 and headquartered in Burnaby, Canada, D-Wave has expanded its presence with sales offices in the United States, Europe, and Asia.

Oris4

Venture Round in 2012
Oris4 is a cloud-based enterprise content management platform that focuses on enhancing the organization and retrieval of content across various channels. It integrates multiple cloud storage solutions, such as Box, Dropbox, and Google Drive, alongside email applications like Gmail and Office 365, allowing users to consolidate their information sources. Additionally, Oris4 is fully integrated with Salesforce, enabling users to access all account-related content directly on their Salesforce pages. This comprehensive approach streamlines content management, making it easier for organizations to store, share, and search for vital information efficiently.

GenoLogics

Series D in 2012
GenoLogics, Inc. is a company that specializes in laboratory information management systems designed to enhance the diagnosis and treatment of diseases. Based in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers the BaseSpace Clarity LIMS, a solution utilized by research and clinical laboratories to efficiently track samples from receipt to result. This system aims to reduce costs, improve accuracy, and ensure rigorous quality control. The company focuses on translational medicine, genomics sequencing, systems biology research, and data management across multiple laboratories, facilitating collaborative initiatives in biomedical research. Founded in 2002, GenoLogics operates as a subsidiary of Illumina Inc., contributing to advancements in early disease detection, prevention, and treatment.

Global Ad Source

Venture Round in 2012
Global Ad Source specializes in advertising research services that deliver real-time information about competitor ad campaigns. By monitoring over 70 markets, the company provides clients with accessible copies of advertisements across various media, including television, print, online platforms, and social media channels such as Facebook, Twitter, Instagram, and YouTube. This comprehensive coverage allows brands and agencies to conduct thorough research on market trends and advertising strategies without significant time or financial investment. By keeping clients informed about breaking competitor advertising, Global Ad Source enables them to navigate the evolving landscape of consumer touchpoints effectively.

Enovex Technology

Venture Round in 2012
Enovex Technology, established in 2009 and headquartered in Saint John, Canada, specializes in the design and development of advanced gas separation materials. The company's core focus is on creating innovative solutions for capturing and separating greenhouse gases, with a particular emphasis on carbon dioxide, nitrogen, and water. Enovex's cutting-edge materials are not only applicable in traditional gas separation and production processes but also extend to high-value industrial gases, advanced agriculture, and emerging technologies such as internet and mobile devices, and biomedical applications.

MedRunner

Seed Round in 2012
MedRunner Health Solutions Inc. is a software development company based in Saint John, Canada, specializing in healthcare applications for prescribers, pharmacists, and patients. Established in 2009, the company has developed MedRunner, a web-based electronic prescription platform that enables physicians and pharmacies to exchange electronic prescriptions efficiently. Additionally, MedRunner offers ePrescribing, which allows legal prescribers to send paperless prescriptions to pharmacies, thereby mitigating the risks associated with traditional prescription methods. The company's commitment to innovation is reflected in its focus on understanding and addressing the needs of its customers in the healthcare sector.

Spinzo

Seed Round in 2012
Spinzo Corporation, founded in 2011 and based in Rothesay, Canada, specializes in developing a web-based smart buying platform that utilizes dynamic pricing to connect merchants and consumers. The platform is particularly effective for ticket sales, as it integrates with Ticketmaster to automatically reserve seats from available or previously held inventory. This integration not only streamlines the ticket purchasing process but also enhances group experience tracking, which helps sales representatives, managers, and group leaders motivate their teams to achieve specific sales milestones. By leveraging innovative technology, Spinzo aims to facilitate efficient ticket sales and improve the overall purchasing experience for both retailers and customers.

MSI Methylation Sciences

Series A in 2011
MSI Methylation Sciences, Inc. is a biotechnology company based in Canada that focuses on developing oral and small molecule therapies for the adjunctive treatment of Major Depressive Disorder (MDD). Founded in 2007, the company is known for its product Strada, an orally administered therapy designed to alleviate symptoms of depression in MDD patients. Additionally, MSI develops S-Adenosyl Methionine, a prescription drug that serves as a dietary supplement. The company aims to reduce drug development risk while providing effective treatment options based on ademetionine, a naturally occurring molecule crucial for various biochemical processes in the body.

gShift

Series A in 2011
gShift is an enterprise SEO, Web presence analytics and content performance platform designed to help agency and brand marketers optimize, monitor and report on the performance of their multi-channel owned, earned and paid campaigns from search through to conversion. gShift’s software infrastructure has been collecting and storing web presence data since 2009. More than 10,000 brands in 24 countries benefit from gShift’s insight data and software, as they optimize their time to improve the discoverability and the sharing of their content. gShift placed 29th on the PROFIT HOT 50.

Hy-Power Nano

Seed Round in 2011
Hy-Power Nano Inc. specializes in the research and development of nano-based insulating coatings that possess infra-red blocking capabilities. The company’s product line includes nano-coating solutions designed to enhance energy efficiency by keeping heat outside during the summer and retaining warmth in the winter. Additionally, Hy-Power Nano offers a clear glass coating that effectively blocks nearly all ultraviolet rays and a substantial portion of infrared rays, providing significant protection for various applications. This innovative approach allows consumers to utilize architectural coatings that block 99.99 percent of ultraviolet rays and up to 40 percent of infrared rays, contributing to improved thermal comfort and energy savings.

Ambit Biosciences

Series D in 2011
Ambit Biosciences is a privately-held biopharmaceutical company that specializes in the discovery and development of small molecule kinase inhibitors aimed at treating cancer and inflammatory diseases. The company's lead compound, AC220, is a selective and orally bioavailable inhibitor of FMS-like tyrosine kinase-3 (FLT3), currently undergoing clinical trials for patients with relapsed or refractory acute myeloid leukemia (AML). Ambit is collaborating with Astellas Pharma Inc. to jointly develop and commercialize FLT3 kinase inhibitors across various therapeutic areas. In addition to AC220, Ambit's clinical pipeline features AC480, a pan-HER inhibitor, and AC430, an oral inhibitor of JAK2. Furthermore, the company has several preclinical candidates, including CEP-32496, a BRAF inhibitor that is licensed to Cephalon. Through its innovative approach, Ambit aims to enhance treatment outcomes for cancer patients.

Perspecsys

Series A in 2011
Perspecsys specializes in cloud data protection, focusing on privacy, residency, and security solutions for businesses utilizing cloud-based applications. Their technology, known as the Cloud Protection Gateway, enables organizations to adopt cloud applications while maintaining complete control over their sensitive data. By ensuring that valuable data does not leave the company's environment, Perspecsys mitigates the risks associated with data transfer, processing, and storage. This approach effectively transforms public cloud infrastructure into a more secure private cloud, addressing key compliance and security challenges that organizations face when integrating cloud computing services. Ultimately, Perspecsys empowers enterprises to leverage the benefits of cloud technology without compromising on data security.

General Fusion

Series B in 2011
General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.

Lymbix

Venture Round in 2011
Lymbix, Inc. is a technology innovation company founded in 2009 and headquartered in Moncton, Canada. It specializes in real-time sentiment analytics technologies that enhance the clarity of written communication. Lymbix's suite of products includes ToneCheck, which acts as an emotional spell checker by analyzing the tone of messages before they are sent; Measure.ly, a content marketing analytics solution that connects social media efforts with content marketing; and TweetTone, which evaluates the emotional content of conversations on Twitter. The company also offers Benchmark21 for industry conversion rate benchmarks and various reporting tools through its Measurely Dashboard and Measurely Report Engine. Additionally, Lymbix provides the LymbixAPI, allowing developers and partners in sectors like Social CRM and Customer Support to integrate advanced sentiment analysis into their applications. By incorporating an emotional dimension into sentiment analysis, Lymbix aims to provide a more nuanced understanding of communication.

ClearRisk

Venture Round in 2011
ClearRisk, Inc. specializes in providing cloud-based software solutions tailored for the insurance industry in North America. Founded in 2006 and based in St. John's, Canada, the company offers three main products: ClearRisk Manager, an online platform that helps organizations develop and implement risk management plans; ClearRisk Tracker, designed for mid-market municipalities to manage insurance claims, exposures, incidents, and policies; and ClearRisk Underwriter, a web application that facilitates automation and collaboration for insurance brokers and underwriters. ClearRisk's solutions enable insurance professionals, including brokers and risk managers, to efficiently organize, analyze, and automate their risk and claims data, ultimately enhancing their risk management capabilities. The company was previously known as Livyer Enterprises Ltd. before rebranding in August 2008.

Boreal Genomics

Series B in 2010
Boreal Genomics Inc. is a biotechnology company that focuses on the development and commercialization of technologies for blood-based detection and monitoring of circulating tumor DNA. Founded in 2007 and headquartered in Los Altos, California, with an additional office in Vancouver, Canada, the company offers products like OnTarget, which allows for the sensitive detection and quantification of tumor mutations in plasma or tissue. Boreal's platform is designed to enable healthcare professionals to perform accurate genomic profiling and monitor tumor evolution from cell-free DNA in plasma, thereby improving cancer patient care. The OnTarget assay, available as a research-use service, reveals tumor mutations that may be undetectable by other methods, assisting in therapy selection, enhancing clinical trial efficiency, and expediting drug development. Additionally, Boreal provides DNA enrichment and library construction solutions tailored for high accuracy sequencing in liquid biopsy applications.

Covarity

Venture Round in 2010
Covarity, Inc. specializes in developing online solutions for post-origination commercial loan monitoring and analysis, aimed at enhancing the performance and health of financial institutions' loan portfolios. The company automates the collection and analysis of borrower financial data, allowing lenders to manage credit risk on an individual loan basis. Covarity's services include borrower tracking, financial document parsing, and portfolio reporting, which provide the insight and control necessary for lenders to grow their portfolios while minimizing risk and improving client service. Its modular software solutions are tailored to meet the specific needs of banks, credit unions, and other lenders in Canada, helping them manage collateral reviews and financial assessments efficiently. Founded in 1999 and based in Kitchener, Canada, Covarity serves notable clients such as RBC Financial, BMO Financial, and Laurentian Bank, enabling them to enhance competitiveness and reduce operational costs.

Celator Pharmaceuticals

Series D in 2010
Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

Morega Systems

Series B in 2010
Morega Systems Inc. is a software and consumer product company that specializes in advanced media mobility solutions tailored for the digital home. The company develops software and services that facilitate multimedia portability and streaming for business customers globally. With capabilities in transcoding, transcrypting, and quality of service-aware streaming, Morega offers comprehensive solutions for premium service operators and hardware vendors. Their applications include side-loading, place-shifting, and targeted ad insertion, enhancing consumer experiences with innovative products that enable seamless access to both premium and personal media content. Additionally, Morega utilizes a remote proxy server to manage network addresses, ensuring consumers can easily access pictures, music, and video on any IP device.

Copperleaf

Series A in 2010
Copperleaf Technologies Inc. offers enterprise software solutions designed for asset-intensive organizations facing challenges related to aging infrastructure, both in Canada and internationally. The company specializes in decision analytics that help clients optimize capital planning, asset life cycle planning, and budgeting. Its key products include Copperleaf C55, a software solution for asset investment planning and management that enables organizations to make risk-informed decisions by utilizing real data to forecast performance and evaluate investment options. Additionally, Copperleaf provides Copperleaf ESP, a solution for demand-side management that allows utilities to design, analyze, and manage their demand-side projects. Serving industries such as electrical power generation, transmission, distribution, and gas and water utilities, Copperleaf has established a global network of expert partners to distribute and support its solutions. Founded in 2000 and headquartered in Burnaby, Canada, Copperleaf is recognized for its commitment to advancing asset management standards and has been acknowledged as one of Canada’s fastest-growing software companies.

Redlen Technologies

Venture Round in 2010
Redlen Technologies Inc. specializes in manufacturing cadmium zinc telluride (CZT) semiconductors, which are essential for radiation detection and imaging equipment used in various applications such as nuclear cardiology, CT scanning, baggage scanning, and bomb detection. Founded in 1999 and based in Saanichton, Canada, the company has pioneered a unique production process known as the Traveling Heater Method (THM) to create advanced CZT semiconductor wafers. This innovation enhances the performance, cost-efficiency, and availability of radiation detection technologies, facilitating their adoption in both medical and security sectors. Additionally, Redlen provides high-purity cadmium telluride feedstock solutions for thin film solar photovoltaic applications, thereby contributing to the renewable energy market. With a strong focus on advancing semiconductor and imaging technology, Redlen Technologies is positioned as a leader in high-performance detection solutions.

Vitrium Systems

Venture Round in 2010
Vitrium Systems Inc. specializes in document security and digital rights management (DRM) software tailored for various file formats, including PDF, office documents, and images. Founded in 2005 and based in Vancouver, Canada, the company provides solutions that allow content creators, publishers, and distributors to safeguard proprietary and confidential materials. Vitrium's offerings encompass document security, secure file sharing, image protection, and analytics, as well as consulting and support services. Its technology integrates seamlessly with existing enterprise systems, enabling organizations to implement military-grade encryption and file-level protection. This facilitates the secure distribution of documents and images through various channels, including websites and email, while providing insights into user engagement through tracking and auditing capabilities. Vitrium serves a diverse range of industries, including education, finance, media, and technology, and has reached a global audience of over a million users.

Bering Media

Series A in 2010
Bering Media specializes in providing innovative technology solutions for Internet Service Providers and advertisers, focusing on hyperlocal geo-targeting capabilities. The company's unique doubleblind privacy technology enables advertisers to utilize carrier data across various networks while ensuring that sensitive information remains secure within the carriers' own infrastructures. This platform is widely adopted by nearly all US broadband service providers, facilitating effective marketing campaigns for both local and national advertisers. Additionally, Bering Media offers privacy-compliant data matching services, supporting the marketing efforts of existing TV sales teams and the carriers' own marketing departments.

Sampling Technologies

Venture Round in 2010
STI is a marketing solutions provider to the healthcare industry. Our focus is on the safe and effective delivery of innovative pharmaceutical and device sampling programs and marketing solutions for manufacturers. STI provides sales, marketing, and regulatory efficiencies to manufacturers, physicians, patients and pharmacists. STI's SmartTechnologyâ„¢ solutions provide tangible benefits to all stakeholders.

Switch Materials

Series B in 2010
Switch Materials Inc. specializes in innovative smart window solutions for the automotive industry, catering to original equipment manufacturers (OEMs) and Tier 1 suppliers. Founded in 2007 and located in Burnaby, Canada, the company focuses on developing advanced materials based on proprietary organic molecules that can change their optical properties upon command. This technology enables various applications, including photochromic and electrochromic systems that automatically adjust the tint of sunroofs to minimize heat and glare. Additionally, Switch Materials' expertise extends to molecular electronics and health sciences, with potential uses in optical filters, photochromic inks, and molecular sensors. The company's research and development is conducted in state-of-the-art laboratories and facilities at 4D LABS, a prominent materials science research center affiliated with Simon Fraser University.

Oris4

Seed Round in 2010
Oris4 is a cloud-based enterprise content management platform that focuses on enhancing the organization and retrieval of content across various channels. It integrates multiple cloud storage solutions, such as Box, Dropbox, and Google Drive, alongside email applications like Gmail and Office 365, allowing users to consolidate their information sources. Additionally, Oris4 is fully integrated with Salesforce, enabling users to access all account-related content directly on their Salesforce pages. This comprehensive approach streamlines content management, making it easier for organizations to store, share, and search for vital information efficiently.

General Fusion

Series A in 2009
General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.

Covarity

Venture Round in 2009
Covarity, Inc. specializes in developing online solutions for post-origination commercial loan monitoring and analysis, aimed at enhancing the performance and health of financial institutions' loan portfolios. The company automates the collection and analysis of borrower financial data, allowing lenders to manage credit risk on an individual loan basis. Covarity's services include borrower tracking, financial document parsing, and portfolio reporting, which provide the insight and control necessary for lenders to grow their portfolios while minimizing risk and improving client service. Its modular software solutions are tailored to meet the specific needs of banks, credit unions, and other lenders in Canada, helping them manage collateral reviews and financial assessments efficiently. Founded in 1999 and based in Kitchener, Canada, Covarity serves notable clients such as RBC Financial, BMO Financial, and Laurentian Bank, enabling them to enhance competitiveness and reduce operational costs.

Teradici

Series C in 2009
Teradici Corporation specializes in PC-over-IP (PCoIP) technology, which facilitates the transmission of software images from central servers or workstations to various PCoIP-ready endpoints. This technology enhances the management and provisioning of computing services, supporting diverse work styles including local, remote, and mobile environments. Teradici offers a range of PCoIP solutions, including zero clients, optimized thin clients, hardware accelerators, remote workstation cards, and workstation access software, all designed to provide high-definition, secure computing experiences. The company's offerings also include cloud solutions such as desktop virtualization infrastructure and remote workstation services, along with optimization and monitoring tools. Teradici serves a wide array of clients, including Fortune 500 companies, educational institutions, government agencies, and cloud service providers, and collaborates with OEM partners globally. Founded in 2004 and headquartered in Burnaby, Canada, Teradici emphasizes innovation and has secured over 40 patents to date.

Zeugma Systems

Series C in 2009
Zeugma Systems is a privately held company that specializes in telecommunications equipment and applications for broadband service providers. The company offers the Zeugma Services Node, a service delivery router that consolidates extensive computing resources with advanced capacity and awareness of both services and subscribers in a robust, fully redundant system. This innovative equipment enables service providers to swiftly prototype and launch new revenue-generating services, monitor session flows at a granular level, and manage individual session flows to enforce quality of service policies. Additionally, Zeugma Systems provides Zeugma OSS for configuration and health management of their systems, and Smart Series Applications, which enhance various services like video on demand and voice over IP. Their solutions also support usage-based billing frameworks, reducing the need for multiple edge devices while facilitating standard broadband aggregation and subscriber management functions.

OneChip Photonics

Series A in 2009
OneChip Photonics specializes in the development of optical transceiver chips designed for mass applications. The company has created an integrated fiber-to-the-home transceiver, which is unique in the market. This innovation aims to reduce costs while simultaneously enhancing performance, making it a significant advancement in the field of optical communications. By focusing on these objectives, OneChip Photonics seeks to address the growing demand for efficient and cost-effective optical solutions.

GenoLogics

Series C in 2009
GenoLogics, Inc. is a company that specializes in laboratory information management systems designed to enhance the diagnosis and treatment of diseases. Based in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers the BaseSpace Clarity LIMS, a solution utilized by research and clinical laboratories to efficiently track samples from receipt to result. This system aims to reduce costs, improve accuracy, and ensure rigorous quality control. The company focuses on translational medicine, genomics sequencing, systems biology research, and data management across multiple laboratories, facilitating collaborative initiatives in biomedical research. Founded in 2002, GenoLogics operates as a subsidiary of Illumina Inc., contributing to advancements in early disease detection, prevention, and treatment.

Mixpo

Series B in 2009
Mixpo, Inc. is a Seattle-based company that operates a comprehensive advertising platform specializing in social, display, and video advertising. Founded in 2002, Mixpo provides tools for advertisers, agencies, and media companies to create, deliver, and measure digital advertising campaigns effectively. The platform enhances campaign performance by integrating channels, assets, and providing advanced capabilities such as measurement, bid optimization, targeting, and retargeting. It also offers solutions tailored for brand advertisers, local creative services, national networks, and advertising exchanges. Known for its innovative technology and deep data insights, Mixpo facilitates ad verification and performance analysis across various demographics and devices. As of 2017, Mixpo functions as a subsidiary of Netsertive, Inc.

Layer 7 Technologies

Venture Round in 2009
Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

xkoto

Series C in 2009
Founded in 2005, xkoto's technology platform enables the replication and virtualization of data. The GRIDSCALE Database Load Balancer manages a geographic grid of standard, commercial databases, making them appear virtually as a single local database so that applications become continuously available and horizontally scalable. Through its proven disruptive technology, xkoto currently empowers SMBs and Fortune 100 companies to decrease costs and increase utilization. Recently named one of Deloitte's 2007 Companies-to-Watch, xkoto's technology partners include IBM, Microsoft, Novell, Sun Microsystems and Sybase. xkoto is based in Toronto and Boston.

Bootup Labs

Seed Round in 2008
Bootup Labs was a startup accelerator based in Vancouver, Canada, founded in 2008. It focused on assisting early-stage companies, particularly in the digital media sector, in becoming fundable ventures. The organization recruited promising entrepreneurs and provided them with essential resources, including mentorship, ongoing support, investment, and office space. Through its comprehensive approach, Bootup Labs aimed to help startups define their business models and secure venture financing, ultimately guiding eight companies from inception to a state of readiness for funding.

Sysomos

Seed Round in 2008
Sysomos Inc. is a Toronto-based company that specializes in Software as a Service (SaaS) social media analytics and intelligence management solutions. Established in 2007, Sysomos provides a comprehensive social intelligence platform designed to assist businesses, brands, advertisers, and agencies in navigating the social media landscape. The platform enables users to listen, measure, understand, and engage with social conversations, offering tools such as Heartbeat for real-time social media management, Sysomos MAP as a search engine, and Sysomos Expion for content planning and analytics. Additionally, Sysomos Gaze monitors images for campaign management, while Sysomos Influence identifies key influencers driving brand engagement. The company’s solutions leverage contextual text analytics and data mining technologies to collect vast amounts of social media conversations from various sources, empowering users to make informed business decisions. Sysomos operates as a subsidiary of Meltwater News US Inc. as of April 2018.

Librestream

Venture Round in 2008
Librestream Technologies Inc., established in 2003 and headquartered in Winnipeg, Canada, specializes in mobile video collaboration solutions for Fortune 500 organizations. Its flagship product, Onsight, enables real-time virtual presence for remote experts to assess environments and troubleshoot equipment. Onsight's suite of products includes collaboration software, rugged smart cameras, and management tools, serving diverse industries such as manufacturing, oil and gas, healthcare, and government. Librestream's solutions help enterprises achieve cost-efficiencies through accelerated problem resolution, reduced downtime, and improved productivity. The company has strategic partnerships with industry leaders like Cisco Systems and Verizon Wireless.

Cytochroma

Series C in 2008
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.

Celator Pharmaceuticals

Series C in 2008
Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

iMPath Networks

Venture Round in 2008
iMPath Networks specializes in providing advanced video networking solutions, particularly focusing on HD-CVI cameras designed for surveillance applications. With over 20 years of experience, the company has established itself as a leader in the deployment of complex video networks and the development of Video over IP solutions. Headquartered in Halifax, iMPath operates additional facilities in Ottawa and serves a diverse clientele that includes some of the largest system integrators across North America, Europe, and Asia. The company's products enable high-quality, real-time video and audio recording, facilitating effective surveillance capabilities for users.

Sutus

Venture Round in 2008
Sutus specializes in providing integrated communication and IT services tailored for small businesses with 3 to 25 employees. The company offers a comprehensive software platform called Sutus Business Central, which includes tools for networking, data management, telephone services, security, and collaboration. Sutus supports various operating systems, including Windows, Mac, and Linux, and ensures compatibility with popular applications such as Microsoft Outlook, Entourage, and Apple Mail. Their services encompass network infrastructure, file and data sharing, collaboration tools, and fully integrated telephone handsets, enabling small businesses to enhance their operational efficiency and communication capabilities.

Inimex Pharmaceuticals

Series B in 2008
Inimex Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of Innate Defense Regulators (IDRs). These innovative drugs are designed to selectively modulate the body's innate immune defenses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, reduce tissue damage, and mitigate bacterial infections. Inimex's IDR products target a range of medical conditions, including infections and tissue injury-related ailments such as ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is dedicated to advancing its unique therapies to improve patient outcomes.

BumpTop

Seed Round in 2008
BumpTop is a developer of innovative 3D desktop software that offers users a customizable interface in a three-dimensional environment. This unique platform enables individuals to personalize their screens, incorporating physics-based animations that enhance interaction. Users can manipulate documents by pushing, pulling, and stacking them, creating a more intuitive and engaging way to manage digital files.

Adnavance Technologies

Series B in 2008
Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The company's patented and ultra-sensitive metalized-DNA (M-DNAâ„¢) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.

D-Wave Systems

Series C in 2008
D-Wave Systems Inc. specializes in the development and integration of superconducting quantum computers. As the first commercial supplier of quantum computers, the company offers products such as The D-Wave Two System, D-Wave Hybrid—a hybrid workflow platform for quantum-classical applications—and Leap, a cloud-based service that enables real-time access to quantum computing resources along with open-source development tools and educational materials. D-Wave's quantum computers are applied across various sectors, including defense, finance, energy, and academia, addressing challenges in mission planning, logistics, machine learning, optimization problems, and more. In addition to its quantum computing systems, the company provides professional services, training, and customer support to enhance user experience. Founded in 1999 and headquartered in Burnaby, Canada, D-Wave has expanded its presence with sales offices in the United States, Europe, and Asia.

Azorus

Venture Round in 2008
Azorus Inc. specializes in providing customer relationship management (CRM) solutions tailored for higher education institutions across the United States, Canada, the United Kingdom, and the Netherlands. Founded in 2002 and headquartered in Halifax, Canada, the company focuses on enhancing the recruitment capabilities of its clients by offering a suite of user-friendly, web-based tools. These tools streamline and automate the student admission process, allowing institutions to improve their recruitment and enrollment strategies efficiently. Azorus has positioned itself as a leading CRM provider in the higher education sector, continually developing its platform in collaboration with university clients to meet their specific needs.

Zeugma Systems

Series B in 2007
Zeugma Systems is a privately held company that specializes in telecommunications equipment and applications for broadband service providers. The company offers the Zeugma Services Node, a service delivery router that consolidates extensive computing resources with advanced capacity and awareness of both services and subscribers in a robust, fully redundant system. This innovative equipment enables service providers to swiftly prototype and launch new revenue-generating services, monitor session flows at a granular level, and manage individual session flows to enforce quality of service policies. Additionally, Zeugma Systems provides Zeugma OSS for configuration and health management of their systems, and Smart Series Applications, which enhance various services like video on demand and voice over IP. Their solutions also support usage-based billing frameworks, reducing the need for multiple edge devices while facilitating standard broadband aggregation and subscriber management functions.

CellFor

Venture Round in 2007
CellFor is a prominent supplier of advanced seedlings to the global forest industry, specializing in loblolly pine and other conifer species. The company employs plant biotechnology to identify and cultivate genetically superior seedlings, enhancing growth and resilience without resorting to genetic modification. By focusing on quality and innovation, CellFor aims to support sustainable forestry practices and improve the overall health of forest ecosystems.

xkoto

Series B in 2007
Founded in 2005, xkoto's technology platform enables the replication and virtualization of data. The GRIDSCALE Database Load Balancer manages a geographic grid of standard, commercial databases, making them appear virtually as a single local database so that applications become continuously available and horizontally scalable. Through its proven disruptive technology, xkoto currently empowers SMBs and Fortune 100 companies to decrease costs and increase utilization. Recently named one of Deloitte's 2007 Companies-to-Watch, xkoto's technology partners include IBM, Microsoft, Novell, Sun Microsystems and Sybase. xkoto is based in Toronto and Boston.

BTI Systems

Series D in 2007
BTI Systems Inc. is a company that specializes in developing and marketing cloud and metro networking software and systems for carriers, colocation, content, and service providers, as well as cloud infrastructure companies globally. Its product offerings include the BTI Intelligent Cloud Connect platforms for cloud service delivery, high-bandwidth Packet Optical Transport network infrastructure for various metro and regional services, and Access and Aggregation Platforms for carrier Ethernet business services and mobile backhaul applications. Additionally, BTI provides Ethernet Access Platforms to extend services to customer premises and control software for centralized network management. Founded in 2000 and based in Kanata, Canada, BTI also offers professional services such as network planning, systems engineering, and installation. The company serves over 380 customers worldwide and operates regional sales, marketing, and research and development centers internationally. BTI Systems is a subsidiary of Juniper Networks, as of January 2016.

Neuromed Pharmaceuticals

Series E in 2007
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

Kibboko

Series B in 2007
Kibboko, Inc. designs and develops content management software. The company's product is called Scout. It is a content personalization system for publishers. Served over 30 million unique visitors.

Paymentus

Venture Round in 2007
Paymentus Corporation is a provider of electronic billing and payment solutions in North America, offering a cloud-based, Software-as-a-Service platform designed for direct-bill organizations. Founded in 2004 and headquartered in Charlotte, North Carolina, with additional offices across various U.S. and Canadian cities, Paymentus enables real-time payments through multiple channels, including online, mobile, and interactive voice response. The platform supports a wide range of funding methods and is compliant with tier 1 PCI standards, ensuring secure transactions. Paymentus serves diverse sectors, including utilities, healthcare, insurance, financial services, and government, by integrating with clients' core financial and operational systems to enhance customer engagement and streamline revenue management processes. The company generates revenue primarily through transaction fees associated with the payment services it provides.

Celator Pharmaceuticals

Series C in 2007
Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

Switch Materials

Venture Round in 2007
Switch Materials Inc. specializes in innovative smart window solutions for the automotive industry, catering to original equipment manufacturers (OEMs) and Tier 1 suppliers. Founded in 2007 and located in Burnaby, Canada, the company focuses on developing advanced materials based on proprietary organic molecules that can change their optical properties upon command. This technology enables various applications, including photochromic and electrochromic systems that automatically adjust the tint of sunroofs to minimize heat and glare. Additionally, Switch Materials' expertise extends to molecular electronics and health sciences, with potential uses in optical filters, photochromic inks, and molecular sensors. The company's research and development is conducted in state-of-the-art laboratories and facilities at 4D LABS, a prominent materials science research center affiliated with Simon Fraser University.

Morega Systems

Series A in 2007
Morega Systems Inc. is a software and consumer product company that specializes in advanced media mobility solutions tailored for the digital home. The company develops software and services that facilitate multimedia portability and streaming for business customers globally. With capabilities in transcoding, transcrypting, and quality of service-aware streaming, Morega offers comprehensive solutions for premium service operators and hardware vendors. Their applications include side-loading, place-shifting, and targeted ad insertion, enhancing consumer experiences with innovative products that enable seamless access to both premium and personal media content. Additionally, Morega utilizes a remote proxy server to manage network addresses, ensuring consumers can easily access pictures, music, and video on any IP device.

NowPublic

Series A in 2007
NowPublic is a user-generated social news website that serves as a crowdsourcing news network. It allows individuals to contribute and share news related to politics, culture, entertainment, and various life events through photos and video headlines. The platform aims to connect citizen journalists with major news organizations, facilitating real-time coverage of significant events as they unfold. By leveraging the contributions of everyday users, NowPublic enhances the diversity and immediacy of news reporting, providing a unique perspective on current affairs.

Protiva Biotherapeutics

Venture Round in 2007
Protiva Biotherapeutics, Inc. is a biotechnology company specializing in the development of nucleic acid-based pharmaceutical products aimed at combating a range of human diseases, including cancer, influenza, Ebola, inflammatory conditions, and chronic viral infections. The company’s product portfolio features Pro 1, a tumor cell growth inhibitor, and Pro-101, an siRNA product designed to impede the production of a protein associated with tumor growth. Additionally, Protiva develops Pro-B, which inhibits the expression of apolipoprotein B, as well as Pro-EBOV and Pro-MARV, targeting the replication of the Ebola and Marburg viruses. The company employs Stable Nucleic-Acid Lipid Particle technology for effective delivery of nucleic acid therapies, including short interfering RNA (siRNA). Protiva is also engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics operates a research and development facility in Vancouver, Canada, and is based in Seattle, Washington. As of 2008, it functions as a subsidiary of Tekmira Pharmaceuticals Corp.

NowPublic

Series A in 2007
NowPublic is a user-generated social news website that serves as a crowdsourcing news network. It allows individuals to contribute and share news related to politics, culture, entertainment, and various life events through photos and video headlines. The platform aims to connect citizen journalists with major news organizations, facilitating real-time coverage of significant events as they unfold. By leveraging the contributions of everyday users, NowPublic enhances the diversity and immediacy of news reporting, providing a unique perspective on current affairs.

Distil Interactive

Series A in 2007
Distil Interactive, Ltd. is a company based in Ottawa, Canada, that specializes in developing automated teaching and testing solutions aimed at enhancing personnel skills training and assessment. Founded in 2005, the company offers a digital game-based learning platform designed for certification and training organizations. This platform facilitates the consistent and accurate teaching and assessment of skills and behaviors through interactive and intuitive e-learning methods. Distil Interactive aims to improve the effectiveness of training programs by leveraging technology to create engaging educational experiences.

SiGe Semiconductor

Venture Round in 2007
SiGe Semiconductor, Inc. is a fabless semiconductor company that specializes in designing and manufacturing radio frequency (RF) integrated circuits and multi-chip modules for the wireless consumer electronics market. The company provides a range of products, including wireless LAN front end modules, dual band front end modules, discrete power amplifiers, WiMAX power amplifiers, GPS radio integrated circuits, GPS receivers, and Bluetooth power amplifiers. SiGe Semiconductor distributes its RF solutions through a network of distributors, catering to computing, home entertainment, and mobile device applications across regions including Asia, Europe, the Middle East, and North America.

EQO

Series B in 2007
Like most other players in this space, EQO helps save you money on long distance calls by bridging long distance calls over cheaper IP lines. What essentially happens is that your phone an EQO server on a local number, which transfers your call onto cheaper data lines across the internet, and then hops back onto standard phone lines and through another local number to the callee. The call only costs you minutes from your phone plan and the data cost for the VOIP line which runs 95-98% less than standard calling rates. Callers will store value for phone calls in EQO credits. However, calling another EQO user is free.

Octopz

Venture Round in 2007
Octopz Inc. is a Toronto-based company that specializes in developing online collaboration technologies tailored for creative professionals. Founded in 2007, Octopz offers tools that facilitate teamwork and communication among colleagues and partners through various means, including text messaging, VoIP, and webcams. The platform supports multiple document types and enables users to save, archive, and retrieve their work for future review and feedback. This technology is designed to enhance productivity and streamline the collaborative process for users in creative industries.

Covarity

Venture Round in 2007
Covarity, Inc. specializes in developing online solutions for post-origination commercial loan monitoring and analysis, aimed at enhancing the performance and health of financial institutions' loan portfolios. The company automates the collection and analysis of borrower financial data, allowing lenders to manage credit risk on an individual loan basis. Covarity's services include borrower tracking, financial document parsing, and portfolio reporting, which provide the insight and control necessary for lenders to grow their portfolios while minimizing risk and improving client service. Its modular software solutions are tailored to meet the specific needs of banks, credit unions, and other lenders in Canada, helping them manage collateral reviews and financial assessments efficiently. Founded in 1999 and based in Kitchener, Canada, Covarity serves notable clients such as RBC Financial, BMO Financial, and Laurentian Bank, enabling them to enhance competitiveness and reduce operational costs.

Virtual Expert Clinics

Series C in 2007
Virtual Expert Clinics develops online educational therapy supports for schools and districts to educate students with developmental disorders in Canada and the United States. It offers AutismPro, a subscription-based online program that guides parents, therapists, and teachers to design, build, and manage educational therapeutic programs for children with autism. The company was founded in 2004 and is based in Fredericton, Canada with an additional office in Denver, Colorado.

Sirific Wireless

Series C in 2007
Sirific Wireless is a semiconductor company specializing in the design and development of CMOS RF transceivers for the wireless communications market. Founded in 2000, the company is headquartered in Richardson, Texas, with additional offices in Waterloo, Canada, and Seoul, Korea. Sirific Wireless offers a range of products, including monolithic multi-mode wireless designs, digital direct conversion products, and Harmony-direct upconversion transmitters. Its NEXUS platform integrates multiple wireless standards such as HSDPA, WCDMA, EDGE, GPRS, and GSM, providing on-chip receive diversity for transceivers suitable for multi-mode and multi-band wireless applications.

Targeted Growth

Series D in 2007
Targeted Growth, Inc. is a crop biotechnology company specializing in the development of technologies aimed at enhancing seed size and yield for the agricultural and biofuel sectors. Established in 1998 and headquartered in Seattle, Washington, with additional laboratories in the United States and Canada, the company focuses on developing high-yield and quality-improved food and energy crops such as canola, soybean, sugarcorn, and camelina. By increasing the productivity of these crops, Targeted Growth supports farmers in cultivating raw materials essential for the production of renewable fuels, including ethanol and biodiesel. Through its innovative approaches, the company contributes to advancements in sustainable agriculture and energy production.

Trigence Semiconductor

Series B in 2007
Trigence Semiconductor, Inc. is an audio integrated circuit design and solution provider based in Tokyo, Japan, with additional offices in the United States, Hong Kong, and Taiwan. Founded in 2006, the company specializes in developing digital audio products, including Digital Speaker Modules, which integrate speakers, enclosures, connectors, audio DSPs, and interfaces to meet the audio needs of PCs, tablets, and smartphones. Trigence's technology is designed to enhance audio quality for various consumer electronics, such as computers, headphones, soundbars, and Bluetooth speakers, while ensuring efficient power consumption. The company's products are distributed through various channels, catering to the consumer and IT markets. Trigence is recognized for its innovative algorithms that control speaker response, allowing users to experience high-quality audio in a range of applications.

Sofea

Venture Round in 2007
Sofea Inc. provides Custom Computer Programming Services. The company has headquarters in Toronto, Canada.

Cytochroma

Series C in 2007
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.

PlanetEye

Series A in 2007
PlanetEye is a comprehensive online travel planning service that offers users a range of tools and resources to enhance their travel experience. The platform features a powerful planning tool that allows travelers to create custom and interactive destination guides based on their preferences. Users can explore geotagged photography, access extensive travel content from in-house writers, and utilize advanced mapping technology. At the heart of PlanetEye's offerings is the Travel Pack, which enables travelers to "clip" interesting photographs, attractions, hotels, and restaurants while organizing their travel ideas. This combination of features positions PlanetEye as a valuable resource for those seeking innovative ways to plan their trips.

Aegera Therapeutics

Series C in 2006
Aegera Therapeutics is a clinical stage biotechnology company that specializes in developing targeted therapeutics to meet significant unmet medical needs. The company has multiple clinical programs, focusing primarily on oncology and neuropathic pain. Its oncology initiatives include treatments for various cancers, such as chronic lymphocytic leukemia, acute myeloid leukemia, non-small cell lung cancer, pancreatic cancer, and hepatocellular carcinoma. Additionally, Aegera is exploring therapies for solid tumors and peripheral neuropathy in diabetic patients. The company also works on small molecule inhibitors aimed at treating multiple cancers, as well as inflammatory and autoimmune diseases. Aegera is committed to leveraging its core technologies and expertise to identify and advance novel development candidates from preclinical stages into clinical trials.

GenoLogics

Series B in 2006
GenoLogics, Inc. is a company that specializes in laboratory information management systems designed to enhance the diagnosis and treatment of diseases. Based in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers the BaseSpace Clarity LIMS, a solution utilized by research and clinical laboratories to efficiently track samples from receipt to result. This system aims to reduce costs, improve accuracy, and ensure rigorous quality control. The company focuses on translational medicine, genomics sequencing, systems biology research, and data management across multiple laboratories, facilitating collaborative initiatives in biomedical research. Founded in 2002, GenoLogics operates as a subsidiary of Illumina Inc., contributing to advancements in early disease detection, prevention, and treatment.

Action Pharma

Series A in 2006
Action Pharma A/S is a biotechnology company focused on research and development, specializing in the discovery and development of novel drugs for cardiovascular, inflammatory, and metabolic diseases. Founded in 2000 and based in Holte, Denmark, the company aims to create treatment options for conditions such as type-II diabetes, obesity, kidney injury related to cardiac surgery, inflammatory bowel disease, rheumatoid arthritis, and inflammatory skin diseases like atopic dermatitis. Its product pipeline includes AP214, a modified MSH peptide analogue for post-surgical kidney injury; AP1030 and AP11 series, oral medications for type-II diabetes; AP1189, an anti-inflammatory compound for various inflammatory diseases; and AP405, another modified MSH peptide aimed at treating inflammatory skin conditions. Action Pharma's approach focuses on targeting melanocortin receptors, progressing its candidates toward clinical proof of concept to facilitate future partnerships.

Layer 7 Technologies

Series B in 2006
Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

CellFor

Venture Round in 2006
CellFor is a prominent supplier of advanced seedlings to the global forest industry, specializing in loblolly pine and other conifer species. The company employs plant biotechnology to identify and cultivate genetically superior seedlings, enhancing growth and resilience without resorting to genetic modification. By focusing on quality and innovation, CellFor aims to support sustainable forestry practices and improve the overall health of forest ecosystems.

Distil Interactive

Venture Round in 2006
Distil Interactive, Ltd. is a company based in Ottawa, Canada, that specializes in developing automated teaching and testing solutions aimed at enhancing personnel skills training and assessment. Founded in 2005, the company offers a digital game-based learning platform designed for certification and training organizations. This platform facilitates the consistent and accurate teaching and assessment of skills and behaviors through interactive and intuitive e-learning methods. Distil Interactive aims to improve the effectiveness of training programs by leveraging technology to create engaging educational experiences.

Protiva Biotherapeutics

Series C in 2006
Protiva Biotherapeutics, Inc. is a biotechnology company specializing in the development of nucleic acid-based pharmaceutical products aimed at combating a range of human diseases, including cancer, influenza, Ebola, inflammatory conditions, and chronic viral infections. The company’s product portfolio features Pro 1, a tumor cell growth inhibitor, and Pro-101, an siRNA product designed to impede the production of a protein associated with tumor growth. Additionally, Protiva develops Pro-B, which inhibits the expression of apolipoprotein B, as well as Pro-EBOV and Pro-MARV, targeting the replication of the Ebola and Marburg viruses. The company employs Stable Nucleic-Acid Lipid Particle technology for effective delivery of nucleic acid therapies, including short interfering RNA (siRNA). Protiva is also engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics operates a research and development facility in Vancouver, Canada, and is based in Seattle, Washington. As of 2008, it functions as a subsidiary of Tekmira Pharmaceuticals Corp.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.